These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 6085527

  • 1. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ, Charache S, Boyer SH.
    Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
    [No Abstract] [Full Text] [Related]

  • 2. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG.
    Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R, Veith R, Papayannopoulou T, Stamatoyannopoulos G.
    Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479
    [No Abstract] [Full Text] [Related]

  • 4. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
    Dover GJ, Charache S, Nora R, Boyer SH.
    Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
    [No Abstract] [Full Text] [Related]

  • 5. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1993 Jan 14; 328(2):73-80. PubMed ID: 7677965
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA.
    Adv Pediatr; 1996 Jan 14; 43():309-34. PubMed ID: 8794181
    [No Abstract] [Full Text] [Related]

  • 7. The effects of variable doses of 5-azacytidine on fetal hemoglobin production in sickle cell anemia.
    Dover GJ, Charache SH.
    Prog Clin Biol Res; 1984 Jan 14; 165():73-83. PubMed ID: 6209731
    [No Abstract] [Full Text] [Related]

  • 8. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G.
    N Engl J Med; 1985 Dec 19; 313(25):1571-5. PubMed ID: 2415821
    [Abstract] [Full Text] [Related]

  • 9. Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.
    Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW.
    Prog Clin Biol Res; 1989 Dec 19; 316B():281-93. PubMed ID: 2482498
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM, Pace B.
    Pediatr Pathol Mol Med; 2001 Dec 19; 20(1):87-106. PubMed ID: 12673846
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H, Sutton M, Atweh GF.
    Ann N Y Acad Sci; 2005 Dec 19; 1054():228-37. PubMed ID: 16339670
    [Abstract] [Full Text] [Related]

  • 12. Increasing fetal hemoglobin production in sickle cell disease: results of clinical trials.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1987 Dec 19; 251():455-66. PubMed ID: 2448813
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH.
    Trends Pharmacol Sci; 2006 Apr 19; 27(4):204-10. PubMed ID: 16530854
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1989 Apr 19; 316B():295-306. PubMed ID: 2482499
    [No Abstract] [Full Text] [Related]

  • 16. The effect of increased fetal hemoglobin production on the frequency of vaso-occlusive crisis in sickle cell disease.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1987 Apr 19; 240():277-85. PubMed ID: 2441416
    [No Abstract] [Full Text] [Related]

  • 17. Levels of fetal hemoglobin necessary for treatment of sickle cell disease.
    Noguchi CT, Rodgers GP, Serjeant G, Schechter AN.
    N Engl J Med; 1988 Jan 14; 318(2):96-9. PubMed ID: 2447498
    [No Abstract] [Full Text] [Related]

  • 18. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
    Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1990 Apr 12; 322(15):1037-45. PubMed ID: 1690857
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
    Platt OS.
    Am J Pediatr Hematol Oncol; 1985 Apr 12; 7(3):258-60. PubMed ID: 2416231
    [Abstract] [Full Text] [Related]

  • 20. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production.
    Dover GJ, Humphries RK, Moore JG, Ley TJ, Young NS, Charache S, Nienhuis AW.
    Blood; 1986 Mar 12; 67(3):735-8. PubMed ID: 2418898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.